ALAMEDA, Calif., Nov. 15 /PRNewswire-FirstCall/ -- Cerexa, Inc. (www.cerexa.com) today announced that Dennis G. Podlesak, Chief Executive Officer, will present at the Credit Suisse First Boston Annual Healthcare Conference in Phoenix, AZ on Wednesday, November 16, 2005 at 12:00 p.m. MST (2:00 p.m. EST) at The Arizona Biltmore. Mr. Podlesak will provide a brief corporate overview and discuss the company’s lead product candidate, PPI-0903.
About Cerexa
Cerexa, Inc., located in Alameda, California, is a biopharmaceutical company committed to developing and commercializing a growing portfolio of novel anti-infective therapies for the treatment of serious and life- threatening infections. Cerexa’s lead compound is PPI-0903, a next-generation cephalosporin currently being investigated as a potential treatment for complicated skin and skin-structure infections. For additional company information, please visit www.cerexa.com.
Contacts: Cerexa, Inc. Noonan Russo Stan Abel Jane Petrino (510) 747-3911 (212) 845-4274 seabel@cerexa.comjane.petrino@eurorscg.com
Cerexa, Inc.
CONTACT: Stan Abel of Cerexa, Inc., 510-747-3911, or seabel@cerexa.com; orJane Petrino of Noonan Russo, 212-845-4274, or jane.petrino@eurorscg.com
Web site: http://www.cerexa.com//
